Low risk of serological cross-reactivity between dengue and COVID-19.
Mem Inst Oswaldo Cruz
; 115: e200225, 2020.
Article
in English
| MEDLINE | ID: covidwho-723314
ABSTRACT
In the near future, the overlap of Coronavirus disease 2019 (COVID-19) and dengue epidemics is a concrete threat in tropical regions. Co-epidemics of COVID-19 and dengue could be an overwhelming challenge for health systems in low- and middle-income countries. In this work, we investigated potential serological cross-reactions between COVID-19 and dengue patients. Among 32 COVID-19 positive sera, no positive Dengue virus (DENV) IgG/IgM results were observed. On the other hand, one false-positive result was observed among 44 DENV-positive sera tested for COVID-19 antibodies with each of the two rapid tests used. Further data on accuracy of COVID-19 diagnostic test are urgently warranted.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Pneumonia, Viral
/
Coronavirus Infections
/
Cross Reactions
/
Dengue
/
Antibodies, Viral
Type of study:
Diagnostic study
/
Prognostic study
/
Randomized controlled trials
Limits:
Humans
Language:
English
Journal:
Mem Inst Oswaldo Cruz
Year:
2020
Document Type:
Article
Affiliation country:
0074-02760200225
Similar
MEDLINE
...
LILACS
LIS